NK cell therapy for hematologic malignancies

Int J Hematol. 2018 Mar;107(3):262-270. doi: 10.1007/s12185-018-2407-5. Epub 2018 Jan 27.

Abstract

Natural killer (NK) cells are part of the innate immune system and represent the first line of defense against infections and tumors. In contrast to T cells, NK cells do not require prior antigen sensitization to induce cytotoxicity and do not cause graft-versus-host disease. These, along with other advantages, make NK cells an attractive candidate for adoptive cellular therapy. Herein, we describe the mechanisms of NK cell cytotoxicity, which is governed by an intricate balance between various activating and inhibitory receptors, including the killer cell immunoglobulin-like receptors (KIRs). We illustrate the advantages of NK alloreactivity as demonstrated in various types of hematopoietic stem cell transplants (HSCT), such as haploidentical, human leukocyte antigen-matched related or unrelated donor and umbilical cord blood transplant. We elaborate on different models used to predict NK cell alloreactivity in these studies, which are either based on the absence of the ligands for inhibitory KIRs, presence of activating NK cell receptors and KIR genes content in donors, or a combination of these. We will review clinical studies demonstrating anti-tumor efficacy of NK cells used either as a stand-alone immunotherapy or as an adjunct to HSCT and novel genetic engineering strategies to improve the anti-tumor activity of NK cells.

Keywords: Adoptive immunotherapy; Cord blood; HLA mismatch; Haploidentical; Hematopoietic stem cell transplant; Immunotherapy; KIR; KIR mismatch; NK cells; Natural killer cells; Stem cell transplant.

Publication types

  • Review

MeSH terms

  • Allografts
  • Cord Blood Stem Cell Transplantation
  • Cytotoxicity, Immunologic*
  • Genetic Engineering
  • HLA Antigens
  • Hematologic Neoplasms / therapy*
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Immunotherapy, Adoptive*
  • Killer Cells, Natural / immunology*
  • Receptors, KIR / genetics

Substances

  • HLA Antigens
  • Receptors, KIR